ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $51,000 | +10.9% | 491 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $46,000 | -13.2% | 491 | +9.1% | 0.01% | 0.0% |
| Q1 2022 | $53,000 | +1.9% | 450 | +16.9% | 0.01% | 0.0% |
| Q4 2021 | $52,000 | -14.8% | 385 | 0.0% | 0.01% | -12.5% |
| Q3 2021 | $61,000 | +24.5% | 385 | +3.2% | 0.01% | +14.3% |
| Q2 2021 | $49,000 | -2.0% | 373 | -4.8% | 0.01% | 0.0% |
| Q1 2021 | $50,000 | -27.5% | 392 | -6.2% | 0.01% | -36.4% |
| Q4 2020 | $69,000 | – | 418 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |